- Home
- TXO vs RZLT Comparison
TXO vs RZLT Comparison
Compare TXO & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXO
- RZLT
- Stock Information
- Founded
- TXO 2012
- RZLT 2010
- Country
- TXO United States
- RZLT United States
- Employees
- TXO N/A
- RZLT N/A
- Industry
- TXO Oil & Gas Production
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- TXO Energy
- RZLT Health Care
- Exchange
- TXO Nasdaq
- RZLT Nasdaq
- Market Cap
- TXO 701.2M
- RZLT 819.3M
- IPO Year
- TXO 2023
- RZLT N/A
- Fundamental
- Price
- TXO $13.18
- RZLT $9.47
- Analyst Decision
- TXO Strong Buy
- RZLT Strong Buy
- Analyst Count
- TXO 2
- RZLT 7
- Target Price
- TXO $20.50
- RZLT $14.86
- AVG Volume (30 Days)
- TXO 206.7K
- RZLT 1.5M
- Earning Date
- TXO 11-05-2025
- RZLT 11-07-2025
- Dividend Yield
- TXO 18.26%
- RZLT N/A
- EPS Growth
- TXO N/A
- RZLT N/A
- EPS
- TXO 0.30
- RZLT N/A
- Revenue
- TXO $332,267,000.00
- RZLT N/A
- Revenue This Year
- TXO $32.13
- RZLT N/A
- Revenue Next Year
- TXO $11.48
- RZLT N/A
- P/E Ratio
- TXO $44.40
- RZLT N/A
- Revenue Growth
- TXO 15.94
- RZLT N/A
- 52 Week Low
- TXO $12.61
- RZLT $2.22
- 52 Week High
- TXO $20.70
- RZLT $10.04
- Technical
- Relative Strength Index (RSI)
- TXO 42.55
- RZLT 59.13
- Support Level
- TXO $13.11
- RZLT $9.00
- Resistance Level
- TXO $13.46
- RZLT $9.79
- Average True Range (ATR)
- TXO 0.32
- RZLT 0.53
- MACD
- TXO 0.02
- RZLT 0.01
- Stochastic Oscillator
- TXO 62.81
- RZLT 80.10
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.